Cholamandalam Financial Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 05, 2024 at 03:07 pm IST
Share
Cholamandalam Financial Holdings Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported revenue was INR 68,420.3 million compared to INR 47,767.5 million a year ago. Net income was INR 4,671.3 million compared to INR 3,320.8 million a year ago. Basic earnings per share from continuing operations was INR 24.88 compared to INR 17.69 a year ago. Diluted earnings per share from continuing operations was INR 24.88 compared to INR 17.69 a year ago.
For the nine months, revenue was INR 189,288.5 million compared to INR 130,948 million a year ago. Net income was INR 12,594.6 million compared to INR 8,823.3 million a year ago. Basic earnings per share from continuing operations was INR 67.07 compared to INR 46.99 a year ago. Diluted earnings per share from continuing operations was INR 67.07 compared to INR 46.99 a year ago.
Cholamandalam Financial Holdings Limited is an India-based investment company, holding investments in its subsidiary / associate / joint venture and other group companies. It operates through two segments: Financing, and Insurance. The Company, through its subsidiaries, Cholamandalam Investment and Finance Company Limited (CIFCL), is engaged in non-banking financial business; Cholamandalam MS General Insurance Company Limited (CMSGICL), is engaged in general insurance business, and Cholamandalam MS Risk Services Limited (CMSRSL), is engaged in risk management and engineering solutions business. CIFCL is a financial service provider, which offers vehicle finance, home loans and loans against property to a range of its customers. CMSGICL offers a range of insurance, including motor, travel, health, accident, home, and other types of insurance for its customers. CMSRSL is engaged in providing risk management and engineering solutions in the field of safety, health, and environment.